Vimarsana
Biggest News Aggregation in the World

Page 31 - Oint Inflammation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oint Inflammation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oint Inflammation Today - Breaking & Trending Today

Psychiatrist Effort Prompts Retraction of Antidepressant Paper - Vimarsana News

Psychiatrist Effort Prompts Retraction of Antidepressant Paper

"I thought, you know, wow, this is something that I'm comfortable prescribing that could make a huge difference for my patients."

Nearly 12% of Patients With PsA Need Musculoskeletal Surgery - Vimarsana News

Nearly 12% of Patients With PsA Need Musculoskeletal Surgery

Higher levels of joint damage increased the risk for disease-related surgical procedures.

Insurance Giant's Effort to Deny Coverage to Chronically Ill Patient - Vimarsana News

Insurance Giant's Effort to Deny Coverage to Chronically Ill Patient

After a college student finally found a treatment that worked, the insurance giant wouldn't pay for the costly drugs. His fight to get coverage exposed the insurer's hidden procedures for rejecting claims.

Elevated PCSK9-Psoriasis Link: A New Target for Treatment? - Vimarsana News

Elevated PCSK9-Psoriasis Link: A New Target for Treatment?

The study suggests that "PCSK9 inhibition is causally associated with reduced risk of psoriasis" and has implications for prevention and possibly treatment of psoriasis, the investigators say.

First Humira Biosimilar Launches in US - Vimarsana News

First Humira Biosimilar Launches in US

Amgen's Amjevita will be offered at 5% and 55% below Humira's list price, but patients may not benefit from the more significant discount.